Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
METHODS The authors conducted a cohort study using the TriNetX Research Network, comparing IIH patients treated with GLP-1-RAs to untreated patients, employing propensity score matching
Novo Nordisk A/S is recognized as a leading player in this market, known for its GLP-1 Receptor Agonist therapies that have revolutionized the management of type 2 diabetes and obesity
Not expired or damaged product
For a long time, this medication was the only drug of its type, but in recent years, other GLP-1 agonists have been approved for both the treatment of diabetes and the treatment of obesity
US$ 24.52
US$ 29.57
US$ 24.31
US$ 21.26
US$ 22.36
US$ 28.53
US$ 22.65
US$ 26.13
US$ 21.30
US$ 21.97
